Screener
Arcus Biosciences RCUS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's accounts payable?
- Arcus Biosciences (RCUS) reported accounts payable of $34M in Q2 2026.
- How has Arcus Biosciences's accounts payable changed year-over-year?
- Arcus Biosciences's accounts payable increased by 17.2% year-over-year, from $29M to $34M.
- What is the long-term trend for Arcus Biosciences's accounts payable?
- Over 5 years (2020 to 2025), Arcus Biosciences's accounts payable has grown at a 21.8% compound annual growth rate (CAGR), from $15.68M to $42M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Arcus Biosciences's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude